查詢結果
共有 7 筆符合條件的資料
| 序號 | 篇名 | 作者 | 日期 | 期刊 |
|---|---|---|---|---|
| 1 | 再生醫療製劑之附附款許可制度——以日本藥機法為比較對象【本期企劃】 The Conditional and Termed Permit License Approval on Regenerative Medicine Preparations - In Comparison with the Japanese Act on Securing Quality, Efficacy, and Safety of Products Including Pharmaceuticals and Medical Devices |
張凱鑫 | 2023/06 | 月旦醫事法報告 |
| 2 | 臨床試驗執行委託契約報酬爭議案：契約之定性【學習式判解評析】 Disputes on the Remuneration of CRO in Clinical Trial Commissioned Contract: The Nature of Contract |
吳志正、洪瑞綺 | 2023/03 | 月旦醫事法報告 |
| 3 | COVID-19疫苗及藥品之緊急使用授權【醫事法學教室】 Emergency Use Authorization for Vaccines and Medicines During the COVID-19 Pandemic |
余萬能 | 2021/07 | 月旦醫事法報告 |
| 4 | 新藥臨床試驗受試者招募廣告、新聞宣傳之法規限制【醫事法學教室】 Regulations on Clinical Trial Recruitment and Advertising |
劉宏恩 | 2020/10 | 月旦醫事法報告 |
| 5 | 以虛偽藥品之實驗論文作為廣告用途未違反藥事法【寰宇醫事裁判】 A Pharmaceutical Corporation Is Not Guilty Because Its Forged Essay of Experiments Didn't Violate the Regulation of Unreal Advertising According to the Pharmaceutical Affairs Law |
黃浥昕(編譯) | 2017/12 | 月旦醫事法報告 |
| 6 | 注射年輕血液可回春？【醫事綜探】 Injecting Young Plasma as an Antiaging Treatment |
月旦醫事法報告編輯部 | 2017/06 | 月旦醫事法報告 |
| 7 | 「日本製造物責任法」事例：抗癌劑輸入商因藥物副作用造成病人死亡，是否有說明書記載缺陷的問題？【寰宇醫事裁判】 A Case of Product Liability Act In Japan: Should Anticancer agents Importer Be Blamed For The Deaths of Patients Due To Incomplete Medication Instructions? |
黃浥昕(編譯) | 2016/07 | 月旦醫事法報告 |
